Aqua Bio Technology ASA (OSTO:ABTO) LT-Debt-to-Total-Asset: 0.00 (As of Dec. 2025)

What is Aqua Bio Technology ASA LT-Debt-to-Total-Asset?

Aqua Bio Technology ASA OSTO:ABTO 29 LT-Debt-to-Total-Asset is 0.00 as of Dec. 2025. GuruFocus rates OSTO:ABTO with a GF Score™ of 29/100 and a GF Value™ of kr3.37 (Significantly Overvalued). The stock has 5 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Aqua Bio Technology ASA's long-term debt to total assests ratio for the quarter that ended in Dec. 2025 was 0.00.

Aqua Bio Technology ASA's long-term debt to total assets ratio stayed the same from Sep. 2024 (0.00) to Dec. 2025 (0.00).

Aqua Bio Technology ASA (OSTO:ABTO) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Aqua Bio Technology ASA LT-Debt-to-Total-Asset Related Terms

Aqua Bio Technology ASA LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Aqua Bio Technology ASA's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aqua Bio Technology ASA LT-Debt-to-Total-Asset Chart

Aqua Bio Technology ASA Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.00

0.01

0.10

0.44

0.00

Aqua Bio Technology ASA Quarterly Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Sep24	Dec24	Jun25	Sep25	Dec25
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.00	0.44	0.37	0.00	0.00

29GF Score

Aqua Bio Technology ASA OSTO:ABTO

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Aqua Bio Technology ASA LT-Debt-to-Total-Asset Calculation

Aqua Bio Technology ASA's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )	/	Total Assets (A: Dec. 2025 )
	=	0	/	130.019
	=	0.00

Aqua Bio Technology ASA's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (Q: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2025 )	/	Total Assets (Q: Dec. 2025 )
	=	0	/	130.019
	=	0.00

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.00 mean?

Aqua Bio Technology ASA (OSTO:ABTO) has a LT-Debt-to-Total-Asset of 0.00 as of Dec. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Aqua Bio Technology ASA and its competitors.

Is Aqua Bio Technology ASA's LT-Debt-to-Total-Asset too high?

Aqua Bio Technology ASA's current LT-Debt-to-Total-Asset is 0.00. Overall, Aqua Bio Technology ASA has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Aqua Bio Technology ASA's LT-Debt-to-Total-Asset compare to VRTX and REGN?

Aqua Bio Technology ASA's LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Biotechnology company?

A good LT-Debt-to-Total-Asset depends on the Biotechnology industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Aqua Bio Technology ASA and its competitors. Aqua Bio Technology ASA's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Aqua Bio Technology ASA stock overvalued right now?

Based on GuruFocus' analysis, Aqua Bio Technology ASA (OSTO:ABTO) is currently considered Significantly Overvalued. The stock's GF Value™ is kr3.37, compared to a current price of kr6.82 — trading 102.4% above its estimated fair value. The current LT-Debt-to-Total-Asset is 0.00. Aqua Bio Technology ASA's overall GF Score™ is 29/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Aqua Bio Technology ASA (OSTO:ABTO), the current LT-Debt-to-Total-Asset is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aqua Bio Technology ASA (OSTO:ABTO) Overvalued in 2026?

Based on GuruFocus' analysis, Aqua Bio Technology ASA stock appears to be overvalued. The current stock price of kr6.82 is trading 102.4% above its estimated GF Value™ of kr3.37. GuruFocus considers Aqua Bio Technology ASA to be Significantly Overvalued.

Key valuation signals for OSTO:ABTO:

LT-Debt-to-Total-Asset: 0.00
GF Value™: kr3.37 vs. price of kr6.82 (102.4% above fair value)
GF Score™: 29/100 with 5 warning signs

No single metric tells the full story. See the OSTO:ABTO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aqua Bio Technology ASA Business Description

Industry Healthcare Biotechnology

Comparable Companies OSL:ABS OSL:EXTX OSL:ONCIN OSL:SOFTX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270 RPRX BNTX INSM ROIV INCY MRNA

Other Exchanges ABTEC:Norway 0I8C:UK 3FZ0:Germany

Address Bygdoy Alle, Oslo, NOR, 0257

Website http://www.aquabiotechnology.com

Aqua Bio Technology ASA develops, produces and markets active ingredients for the personal care industry. It creates products for personal care, healthcare, and cosmetics with the help of marine biotechnology. ABT's brands include Moana-Organic skin care and Cuvget-Arctic skin care.

29GF Score

Get the complete analysis for OSTO:ABTO

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr6.82

Price

kr3.37

GF Value

View OSTO:ABTO Analysis

See LT-Debt-to-Total-Asset data for all stocks →